BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 21640499)

  • 1. N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer.
    D'Errico MP; Grimaldi L; Petruzzelli MF; Gianicolo EA; Tramacere F; Monetti A; Placella R; Pili G; Andreassi MG; Sicari R; Picano E; Portaluri M
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e239-46. PubMed ID: 21640499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy.
    Skyttä T; Tuohinen S; Boman E; Virtanen V; Raatikainen P; Kellokumpu-Lehtinen PL
    Radiat Oncol; 2015 Jul; 10():141. PubMed ID: 26159409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy.
    Erven K; Florian A; Slagmolen P; Sweldens C; Jurcut R; Wildiers H; Voigt JU; Weltens C
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1172-8. PubMed ID: 23149005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotoxicity and cancer therapy: treatment-related cardiac morbidity in patients presenting with symptoms suggestive of heart or lung disease.
    Wieshammer S; Dreyhaupt J; Müller D; Momm F; Jakob A; Freund U
    Oncology; 2013; 85(3):137-44. PubMed ID: 23948797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
    Iltumur K; Yavavli A; Apak I; Ariturk Z; Toprak N
    Am Heart J; 2006 May; 151(5):1115-22. PubMed ID: 16644347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of radiation therapy on myocardial cell integrity and pump function: which role for cardiac biomarkers?
    Nellessen U; Zingel M; Hecker H; Bahnsen J; Borschke D
    Chemotherapy; 2010; 56(2):147-52. PubMed ID: 20407242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
    Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
    Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of B-type natriuretic peptide plasma levels in patients with left-sided breast cancer treated with radiation therapy: Results after one-year follow-up.
    D'Errico MP; Petruzzelli MF; Gianicolo EA; Grimaldi L; Loliva F; Tramacere F; Andreassi MG; Pili G; Picano E; Portaluri M
    Int J Radiat Biol; 2015; 91(10):804-9. PubMed ID: 25955228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive analysis of cardiac dose in balloon-based high-dose-rate brachytherapy for left-sided breast cancer.
    Valakh V; Kim Y; Werts ED; Trombetta MG
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1698-705. PubMed ID: 21601371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide-Binding Protein Is an Early Biomarker of Cardiac Function After Radiation Therapy for Breast Cancer.
    Chalubinska-Fendler J; Graczyk L; Piotrowski G; Wyka K; Nowicka Z; Tomasik B; Fijuth J; Kozono D; Fendler W
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1074-1083. PubMed ID: 30991100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study.
    De Sanctis V; Alfò M; Vitiello C; Vullo G; Facondo G; Marinelli L; Burocchi S; Gallo G; Valeriani M; Campanella B; Scalabrino G; Russo I; Salerno G; Cardelli P; Osti MF; De Biase L
    Clin Breast Cancer; 2021 Jun; 21(3):e141-e149. PubMed ID: 33012660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain natriuretic peptide as a cardiac marker of transient radiotherapy-related damage in left-sided breast cancer patients: A prospective study.
    Palumbo I; Palumbo B; Fravolini ML; Marcantonini M; Perrucci E; Latini ME; Falcinelli L; Sabalich I; Tranfaglia C; Schillaci G; Mannarino E; Aristei C
    Breast; 2016 Feb; 25():45-50. PubMed ID: 26547836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric comparison of intensity-modulated radiotherapy plans, with or without anterior myocardial territory and left ventricle as organs at risk, in early-stage left-sided breast cancer patients.
    Tan W; Wang X; Qiu D; Liu D; Jia S; Zeng F; Chen Z; Li B; Xu J; Wei L; Hu D
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1544-51. PubMed ID: 21470785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY; Du JB; Chen YH; Li WZ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
    Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
    Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.